Esperion Therapeutics, Inc. (ESPR)

2.95 +0.06 (+2.08%) USD  |  NASDAQ  |  Jan 21, 15:45
More

Esperion Therapeutics Tobin's Q (Approximate) (Quarterly)

Tobin's Q (Approximate) (Quarterly) Chart

View Tobin's Q (Approximate) (Quarterly) for ESPR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Tobin's Q (Approximate) (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Tobin's Q (Approximate) (Quarterly) Range, Past 5 Years

View Tobin's Q (Approximate) (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Tobin's Q (Approximate) (Quarterly) Benchmarks

View Tobin's Q (Approximate) (Quarterly) Benchmarks
Start Trial
NovaBay Pharmaceuticals, Inc. Upgrade
Palatin Technologies, Inc. Upgrade
Theriva Biologics, Inc. Upgrade
Oragenics, Inc. Upgrade
NanoViricides, Inc. Upgrade